AIDS Vaccine Advocacy Coalition
Center for HIV/AIDS Vaccine Immunology
Collaboration for AIDS Vaccine Discovery
Global Solutions for Infectious Diseases
International AIDS Vaccine Initiative
International AIDS Vaccine Initiative Report
National Institute of Allergy & Infectious Disease
The Body—The Complete HIV/AIDS Resource
The Body Pro—The HIV Resource for Health Professionals
U.S. Department of Veteran Affairs
WHO-UNAIDS HIV Vaccine Initiative
The AIDS InfoNet is a project of the New Mexico AIDS Education and Training Center at the University of New Mexico Health Sciences Center. This page contains a question and answer format on HIV/AIDS vaccines.
The current state of the art in HIV vaccine research is summarized in this section. It includes an overview of all the key routes by which scientists are trying to develop vaccines, and summarizes the key results from studies reported to date.
The goal of AVAC is advocacy to accelerate ethical research and global delivery of AIDS vaccines and other HIV prevention options. Founded in 1995, AVAC is a nonprofit, community- and consumer-based organization that uses public education, policy analysis, advocacy and community mobilization to accelerate the ethical development and global delivery of AIDS vaccines and other HIV prevention options. A lengthy list of links is available by clicking on Links on the left-hand side menu.
The Center for HIV/AIDS Vaccine Immunology is a consortium of universities and academic medical centers established by the National Institute of Allergy and Infectious Diseases under Barton Haynes, M.D., of Duke University. The Center's goal is to solve major problems in HIV vaccine development and design. The CHAVI tests new vaccine strategies to overcome key immunological roadblocks in HIV vaccine design.
The Collaboration for AIDS Vaccine Discovery is an international network of scientists and other experts dedicated to designing a variety of novel HIV vaccine candidates and advancing the most promising candidates to clinical trials.
The Global HIV Vaccine Enterprise is an alliance of independent organizations around the world dedicated to accelerating the development of a preventive HIV vaccine by shared scientific plan, increased resources, and greater collaboration.
The overall mission for Global Solutions for Infectious Diseases is to expand the development of low-cost effective tools for the diagnosis and prevention of infectious diseases afflicting less-developed countries. As a nonprofit organization, GSID focuses its development efforts in parts of the world where these tools are needed the most. Click on Our Programs and then “A Path to an HIV Vaccine” at the top.
The HIV Vaccine Trials Network is an international collaboration of scientists and educators searching for an effective and safe HIV vaccine. The HVTN's mission is to facilitate the process of testing preventive vaccines against HIV/AIDS. The organization conducts all phases of clinical trials, from evaluating experimental vaccines for safety and the ability to stimulate immune responses, to testing vaccine efficacy.
IAVI's mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. Their core mission is to support the development of preventive AIDS vaccines that are not only safe and effective, but also accessible to all people. IAVI invests the bulk of its resources in the research and clinical assessment of candidate vaccines against strains of HIV that are prevalent in the developing world, where some 95 percent of new HIV infections occur.
IAVI Report provides comprehensive coverage of the AIDS vaccine field from the latest scientific research to policy, advocacy and community perspectives, bringing news and analysis, adding context and underscoring trends and gaps in the search for an AIDS vaccine. IAVI Report is published six times a year and has a global readership of more than 14,000 recipients in over 130 countries.
The National Institute of Allergy and Infectious Diseases conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunological, and allergic diseases. For more than 50 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world.
This page contains a large number of links concerning vaccines & HIV/AIDS.
On this web site page are numerous links to reports and white papers on preventive HIV vaccines.
The Well Project is an initiative conceived, developed, and administered by HIV+ women and those who are affected by this disease. This page provides information on AIDS vaccines.
This page contains numerous links on vaccines, trials, vaccine companies, clinical trial databases, and document collections.
The mission of the WHO-UNAIDS HIV Vaccine Initiative is to promote the development, facilitate evaluation, and address future availability of preventive HIV vaccines, with a focus on the need of developing countries.